Results of the present study have consistently shown that the gradually decreased IGF-1 levels among healthy subjects, viral hepatitis patients and HCC patients were partially independent of AST, ALT and total bilirubin levels. This evidence concerns the gene IGF1 and hepatocellular carcinoma.